2nd Quarter - Report
WALGREEN COMPANY for WALGREEN COMPANY
Firm
Client
Income
—
Expenses
$630,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
Issues related to data privacy and HIPAA modernization; no legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| ALETHIA JACKSON | — |
| EDWARD KALETA | — |
Pharmacy PHA
Amending the Social Security Act to allow pharmacists to be reimbursed under Medicare Part B for services provided to patients related to opioid risk factor reduction and opioid antagonist counseling; no legislation. H.R. 1034 and S.B. 640 (the Phair Pricing Act); provisions related to lowering drug prices and reducing "Out-of-Pocket" costs to seniors.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| ALETHIA JACKSON | — |
| EDWARD KALETA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.